REXIPRA FORTE TAB

1. Specifications & General Information
Brand Name: Rexipra Forte
Generic Name: Escitalopram Oxalate and Clonazepam Tablets IP
Product Type: Prescription Medicine (Schedule H Prescription Drug)
Form Factor: Film-coated tablets
Quantity: 15 Tablets per blister pack
Maximum Shelf Life / Expiry Date: October 2027 (EXP. OCT.2027)
Manufacturing Date: November 2025 (MFD. NOV.2025)
Batch Number: B.No. K2502752
Maximum Retail Price (MRP): ₹306.56 (MAX. RETAIL PRICE Rs. 306.56 FOR 15 TABS. INCLUSIVE OF ALL TAXES)
FSSAI / Food Preference: Not Applicable (This is a pharmaceutical medication for neuropsychiatric care, not a dietary supplement or food product).
2. Product Details & Composition (Ingredients)
Each film-coated tablet contains:
Escitalopram Oxalate IP equivalent to Escitalopram: 10 mg
Clonazepam IP: 0.5 mg
Excipients: q.s. (Quantity Sufficient)
Colours Used: Ferric Oxide Yellow USP-NF & Titanium Dioxide IP
3. Directions for Use & Storage
Dose: As directed by the Physician.
How to Use: Tablets should be swallowed whole with water as prescribed by a medical professional. Do not break, crush, or chew.
Storage Instructions: Store protected from moisture, at a temperature not exceeding 25°C. Keep out of the reach of children.
4. Product Description & Regulatory Warnings
Description: Rexipra Forte is a combination central nervous system drug containing an SSRI antidepressant (Escitalopram) and a benzodiazepine anxiolytic (Clonazepam). It is clinically prescribed to treat anxiety disorders, panic disorders, and comorbid depression.
Security Feature: Includes a scannable matrix QR code printed directly on the foil for verification.
Schedule H Prescription Warning: > “SCHEDULE H PRESCRIPTION DRUG – WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.”
5. Manufacturer & Marketed By Information
Manufactured By: INTAS PHARMACEUTICALS LTD.
Manufacturing Plant Address: Bagheykhola, Majhitar, Sikkim – 737 136, INDIA
Manufacturing License Number: Mfg. Lic. No.: M/517/09
Marketed By: Intas Pharmaceuticals Ltd. (identified by the signature INTAS corporate layout and registered trademark stamp).